These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10836199)

  • 1. Induction of estrogen receptor-alpha and -beta activities by synthetic progestins.
    Rabe T; Bohlmann MK; Rehberger-Schneider S; Prifti S
    Gynecol Endocrinol; 2000 Apr; 14(2):118-26. PubMed ID: 10836199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
    Jeng MH; Parker CJ; Jordan VC
    Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogenic activity of synthetic progestins used in oral contraceptives.
    Jordan VC; Jeng MH; Catherino WH; Parker CJ
    Cancer; 1993 Feb; 71(4 Suppl):1501-5. PubMed ID: 8431886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17 beta-estradiol stimulates mouse neuropeptide Y-Y(1) receptor gene transcription by binding to estrogen receptor alpha in neuroblastoma cells.
    Musso R; Maggi A; Eva C
    Neuroendocrinology; 2000 Dec; 72(6):360-7. PubMed ID: 11146419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha.
    Larrea F; García-Becerra R; Lemus AE; García GA; Pérez-Palacios G; Jackson KJ; Coleman KM; Dace R; Smith CL; Cooney AJ
    Endocrinology; 2001 Sep; 142(9):3791-9. PubMed ID: 11517155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells.
    Pasapera AM; Gutiérrez-Sagal R; García-Becerra R; Ulloa-Aguirre A; Savouret JF
    Endocrine; 2001 Dec; 16(3):217-25. PubMed ID: 11954666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of trimegestone: a new potent and selective progestin.
    Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
    Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G; Kohlmeier L; Brenner H
    Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen potency of oral contraceptive pills.
    Chihal HJ; Peppler RD; Dickey RP
    Am J Obstet Gynecol; 1975 Jan; 121(1):75-83. PubMed ID: 1115120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation and action of estrogen receptors alpha and beta in GH3 cells.
    Mitchner NA; Garlick C; Steinmetz RW; Ben-Jonathan N
    Endocrinology; 1999 Jun; 140(6):2651-8. PubMed ID: 10342855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intrinsic transcriptional estrogenic activity of a non-phenolic derivative of levonorgestrel is mediated via the estrogen receptor-alpha.
    García-Becerra R; Borja-Cacho E; Cooney AJ; Jackson KJ; Lemus AE; Pérez-Palacios G; Larrea F
    J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):333-41. PubMed ID: 12589940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential transcriptional regulation of rat vasopressin gene expression by estrogen receptor alpha and beta.
    Shapiro RA; Xu C; Dorsa DM
    Endocrinology; 2000 Nov; 141(11):4056-64. PubMed ID: 11089536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of oestrogens and progesterone on oestrogen receptors in female rat liver.
    Marr W; Elder MG; Lim L
    Biochem J; 1980 Sep; 190(3):563-70. PubMed ID: 7470070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of levonorgestrel and ethinylestradiol on brain aromatase (cyp19a1b) in zebrafish specific in vitro and in vivo bioassays.
    Hinfray N; Tebby C; Garoche C; Piccini B; Bourgine G; Aït-Aïssa S; Kah O; Pakdel F; Brion F
    Toxicol Appl Pharmacol; 2016 Sep; 307():108-114. PubMed ID: 27491593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hormonal regulation of platelet-activating factor-acetylhydrolase in the rat.
    Yasuda K; Johnston JM
    Endocrinology; 1992 Feb; 130(2):708-16. PubMed ID: 1733719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.